Cargando…

Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B-cell lymphoma

Lysosomal protein transmembrane 4β (LAPTM4B) is an oncogene that is overexpressed in a number of various types of human cancer. There are two known alleles of LAPTM4B: LAPTM4B*1 and LAPTM4B*2. The present study assessed the association between LAPTM4B polymorphisms and the susceptibility to diffuse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Huirong, Cheng, Xiaojing, Ding, Ning, Tian, Zhihua, Zhu, Jun, Zhou, Chunlian, Shen, Jing, Song, Yuqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768069/ https://www.ncbi.nlm.nih.gov/pubmed/29387221 http://dx.doi.org/10.3892/ol.2017.7318

Ejemplares similares

Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers
por: Cheng, Xiaojing, et al.
Publicado: (2016)

Single nucleotide polymorphisms of CD20 gene and their relationship with clinical efficacy of R-CHOP in patients with diffuse large B cell lymphoma
por: Ding, Huirong, et al.
Publicado: (2013)

LAPTM4B Allele *2 Is Associated with Breast Cancer Susceptibility and Prognosis
por: Li, Xiaoyan, et al.
Publicado: (2012)

Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
por: Hu, Yunfei, et al.
Publicado: (2014)

Homozygous A polymorphism of the complement C1qA(276) correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP
por: Jin, Xuan, et al.
Publicado: (2012)

Relationship Between LAPTM4B Gene Polymorphism and Susceptibility of Malignant Melanoma in Chinese Patients
por: Zhang, Meng, et al.
Publicado: (2014)

LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis
por: Mo, Cuiju, et al.
Publicado: (2014)

Different sensitivity of germinal center B cell-like diffuse large B cell lymphoma cells towards ibrutinib treatment
por: Zheng, Xiaohui, et al.
Publicado: (2014)

Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma
por: Tong, Yong, et al.
Publicado: (2018)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma
por: Zhai, Guojun, et al.
Publicado: (2012)

Immune targeted therapy for diffuse large B cell lymphoma
por: Zheng, Yaxin, et al.
Publicado: (2021)

LAPTM4B promotes the progression of nasopharyngeal cancer
por: Su, Qun, et al.
Publicado: (2021)

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients
por: Shaker, Olfat, et al.
Publicado: (2015)

The relationship between LAPTM4B polymorphisms and cancer risk in Chinese Han population: a meta-analysis
por: Xia, Ling-Zi, et al.
Publicado: (2015)

LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta‐analysis
por: Hashemi, Mohammad, et al.
Publicado: (2018)

LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients
por: Cheng, Xiaojing, et al.
Publicado: (2015)

Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma
por: He, Yizi, et al.
Publicado: (2019)

EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP
por: Li, Jiao, et al.
Publicado: (2017)

Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis
por: Cioroianu, Alexandra Ioana, et al.
Publicado: (2019)

Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma
por: Zhou, Weiling, et al.
Publicado: (2022)

The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma
por: Wu, Jianbo, et al.
Publicado: (2023)

Non-Coding RNAs in Diffuse Large B-Cell Lymphoma
por: Shi, Yan, et al.
Publicado: (2020)

Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis
por: Zhou, Linghui, et al.
Publicado: (2018)

LAPTM4B: an oncogene in various solid tumors and its functions
por: Meng, Y, et al.
Publicado: (2016)

Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
por: Luan, Chunyan, et al.
Publicado: (2020)

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
por: Li, Yang, et al.
Publicado: (2010)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma
por: Yang, Hua, et al.
Publicado: (2012)

Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
por: Li, Sha, et al.
Publicado: (2017)

Primary breast diffuse large B cell lymphoma
por: Guo, Mengni, et al.
Publicado: (2022)

LAPTM4B facilitates tumor growth and induces autophagy in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2019)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma
por: Tian, Chen, et al.
Publicado: (2020)

Establishment of a typing model for diffuse large B-cell lymphoma based on B-cell receptor repertoire sequencing
por: Jiang, Wenhua, et al.
Publicado: (2021)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
por: Taskinen, Minna, et al.
Publicado: (2014)

Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma
por: Fei, Fei, et al.
Publicado: (2022)

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma
por: Bernatsky, Sasha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_62c49fiq7qnm970fi435r5l08f